Secukinumab Open Label Roll-over Extension Protocol

ClinicalTrials.gov ID: NCT04638647

Public ClinicalTrials.gov record NCT04638647. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Sep 4, 2026, 11:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-label, Multi-center Protocol for Patients Who Have Completed a Previous Novartis Sponsored Secukinumab Study and Are Judged by the Investigator to Benefit From Continued Secukinumab Treatment

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to assess long term safety in participants who have completed a Novartis trial with secukinumab, have been judged by the investigator to benefit from continued treatment with secukinumab, and are unable to obtain the marketed secukinumab formulation.

Study identification

NCT ID: NCT04638647
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 4
Lead sponsor: Novartis Pharmaceuticals; Industry
Enrollment: 1,000 participants

Conditions and interventions

Conditions

Autoimmunity, Inflammation

Interventions

Secukinumab s.c. injection Biological

Biological

Eligibility (public fields only)

Age range: 6 Years to 100 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Dec 21, 2020
Primary completion: Jan 28, 2030
Completion: Apr 3, 2030
Last update posted: Aug 17, 2026

2020 – 2030

United States locations

U.S. sites: 28
U.S. states: 16
U.S. cities: 28

Facility	City	State	ZIP	Site status
Providence Medical Foundation	Fullerton	California	92835	Completed
Purushotham Akther and Roshan Kotha MD Inc	La Mesa	California	91942	Completed
Precn Comprehensive Clnl Rsch Solns	San Leandro	California	94578	Completed
Orrin Troum MD and Medical Associates	Santa Monica	California	90404	Completed
Inland Rheumatology Clinical Trials INC	Upland	California	91786	Completed
Medvin Clinical Research	Van Nuys	California	91405	Completed
Center for Rheumatology Research	Woodland Hills	California	91364	Completed
Denver Arthritis Clinic	Denver	Colorado	80230	Completed
Rheumatology Associates of South Florida	Boca Raton	Florida	33486	Recruiting
Homestead Assoc In Research Inc	Homestead	Florida	33033	Completed
IRIS Research and Development	Plantation	Florida	33324	Completed
Conquest Research	Winter Park	Florida	32789	Completed
FL Medical Clinic Orlando Health	Zephyrhills	Florida	33542	Recruiting
Willow Rheumatology Wellness	Willowbrook	Illinois	60527	Completed
Dawes Fretzin Clinical Rea Group	Indianapolis	Indiana	46256	Completed
Klein and Associates	Hagerstown	Maryland	21740	Completed
Ahmed Arif Medical Research Center	Grand Blanc	Michigan	48439	Completed
Physician Research Collaboration	Lincoln	Nebraska	68516	Completed
Arthritis Rheumatology and Bone Disease Associates PA	Voorhees Township	New Jersey	08043	Completed
St Lawrence Health System	Potsdam	New York	13676	Completed
Oregon Health Sciences University	Portland	Oregon	97239	Completed
Altoona Center for Clin Res	Duncansville	Pennsylvania	16635	Active, not recruiting
West Tennessee Research Institute	Jackson	Tennessee	38305	Active, not recruiting
Austin Regional Clinic Rheumatology	Austin	Texas	78731	Completed
Accurate Clinical Research Inc	Houston	Texas	77089	Active, not recruiting
Southwest Rheum Rsrch LLC	Mesquite	Texas	75150	Completed
Overlake Arthritis and Osteoporosis	Bellevue	Washington	98004	Completed
Rheumatology Pulmonary Clinic	Beckley	West Virginia	25801	Completed

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 137 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT04638647, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 17, 2026 · Synced Sep 4, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04638647 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →